Market and market research report opinion about revenue impact?
Globalism cell disintegration market Volume is expected to reach $561 million by 2026 from $282 million in 2021, at a compound annual growth rate of 14.7% over the forecast period.
Factors responsible for growth and in-depth analysis?
The growth of the cell disintegration market is primarily driven by the increasing penetration of cell-based research, and the growing number of pharmaceutical and biotechnology companies.
The major players in the biopharmaceutical industry focus on research and development in various therapeutic areas to introduce new drugs into the market. For this, these companies invest heavily in various research activities such as clinical trials, efficacy studies, and toxicity studies. The majority of these studies require tissue disintegration products in order to isolate cells from primary tissues.
Download PDF brochure:
Leading Key Players and Analysis:
Some of the major players operating in the cell disintegration market are Thermo Fishers Scientific (US), Merck KgaA (Germany), Roche Diagnostics (Switzerland), Becton, Dickinson and Company (US). In 2020, Thermo Fishers Scientific took a leading position in the market. The company has a strong geographic presence across the United States, Asia, Europe, the Middle East, Africa and the Americas. Moreover, the company’s strong brand recognition and comprehensive product portfolio in the market is its main strength. Merck Kja It ranked second in the market in 2020.
Thermo Fishers Scientific (USA) Established a leading position in the cell lysis market (enzymatic lysis products and non-enzymatic lysis products) in 2021. Thermo Fishers Scientific Healthcare offers a comprehensive product line consisting of various cell lysis products. The company believes in organic and inorganic growth to strengthen its market position such as product launches and partnership. For example, in 2020, Thermo Fishers Scientific teamed up with Symphogen (Denmark) to expand its strategic collaboration with Symphogen to advance biopharmaceutical discovery and development. Thermo Fisher Scientific acquires QIAGEN NV (Germany) to expand its range of specialist diagnostics.
Geographical analysis in detail?
The cell disintegration market is divided into four major regional segments, namely North America, Europe, Asia Pacific, and Rest of the World. In 2020, North America captured the largest share of the market. The large share of North America can be primarily attributed to the increased research in the pharmaceutical and biotechnology industries and the strong presence of major market players in this region.
Request form pages:
Enzymatic lysis products accounted for the largest share of cell lysis market in 2020
Based on the product, enzymatic dissociation products, non-enzymatic dissociation products and tools. In 2020, the enzymatic lysis products segment captured the largest share of the cell lysis market. The large share of this fraction can be attributed to the increased incidence of cell-based research.
the Connective tissue segment captured the largest market share in 2020
Based on the tissues, they are divided into connective tissue, epithelial tissue and other tissues (skeletal and muscle tissue). Connective tissue segment captured the largest market share in 2020. The increasing incidence is attributed to cell-based research and development in pharmaceutical and biotechnology companies.
tissue disintegration Captured the largest market share in 2020
Based on the type, the cell disintegration market is segmented into tissue disintegration solution and cell disintegration. Tissue Disintegration Solutions segment captured the largest market share in 2020. Increased R&D expenditures in the pharmaceutical and biotechnology industries are driving the growth of this segment.
Talk to the analyst: